What’s Behind the Surge in Pharmaceutical Deals?

Aug. 25 (Bloomberg) –- Bloomberg’s Shannon Pettypiece discusses Roche’s $8.3 billion offer for InterMune and big pharmaceutical deals. She speaks on “Bottom Line.” (Source: Bloomberg)
A Nuclear Deal for Iran
56:35 - Bottom Line's Encore segment, a recap this weeks top stories. (Source: Bloomberg)
  • How Will Apple Impact the Dow?
  • Will Stocks Continue to Selloff on Jobs Report?
  • The Apple Effect: Does Being Added to the Dow Matter?